Diamyd Medical AB Discussing Potential Consolidation of Phase III Trials
STOCKHOLM, Sweden, April 16, 2009 (GLOBE NEWSWIRE) -- Diamyd Medical is conducting two clinical Phase III trials of the Diamyd(r) diabetes vaccine in children and adolescents with recent onset type 1 diabetes: one in the U.S. and one in nine European countries. In parallel, the company is discussing with the regulatory agencies about combining the two trials into one global trial.